ICH-Q7 GMP Manufactured Product
Dextran Sulfate Sodium Salt, MW 8,000
*Low Bioburden, Low Endotoxin
ANALYSIS |
SPECIFICATIONS |
||
---|---|---|---|
|
Off White to light yellow powder |
||
|
≤ 0.9 OD unit |
||
|
≤ 1000 ppm |
||
Endotoxin |
≤ 0.012 EU/mg |
||
|
≤ 0.2% |
||
Glucose |
35 - 48% |
||
|
Passes Test |
||
Insoluble Iron |
≤ 2% |
||
Loss on Drying | ≤ 10% | ||
Manganese (As Reported) | ≤1ppm | ||
pH (1% Solution) |
5.0 to 7.5 |
||
Residue on Ignition |
35 - 50% |
||
Pyridine |
≤ 2% |
||
Specific Rotation [α]D20 |
+75° to 105° |
||
Specific Viscosity (In 1.0M NaCl at 25°C) |
0.018 – 0.032 |
||
Total Bioburden |
≤100CFU/g |
||
Sulfur |
17 - 20% |
Printable Version
Bio Pharma Grade Dextran Sulfate 8000 Na, DXSE-4250 is suitable for use as a process chemical. It is manufactured in accordance with the IPEC-PQG Joint Good Manufacturing Practice Guide. This grade of Dextran Sulfate 8000 Na is not suitable to be used as an Active Pharmaceutical Ingredient, Drug, Drug Product or Household Item.
The recommended expiration period for Dextran Sulfate 8000 Na is two years from the date of manufacture.
Store at Room Temperature
10kg, 25kg and 50kg pails.
American Manufactured - FDA Registered GMP Facilities: Parenteral Excipients, GMP Small Molecule Intermediates, GMP Biological Buffers, Parenteral Carbohydrates, GMP Chlorinated Amino Acids, GMP Solutions in Sterile Single Use Packaging and other Reagent & GMP Fine Chemicals.